Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

Although the novel cytidin analogue gemcitabine has shown superior anti-tumour activity than 5-fluorouracil in advanced pancreatic cancer, further improvements of therapeutic results are warranted. This goal might be achieved by combining gemcitabine with other active drugs. This trial evaluated the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 1999
Pynciau:
Regular Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363123/
https://ncbi.nlm.nih.gov/pubmed/10468299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690600
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg